Quick Takeaways
- NEO - NEOGENOMICS INC has 37 insiders with reported activity on this page.
- Net insider value flow over the last year: +$220,715.
- Recent transaction rows are available for direct filing-level review.
- Info
- Insider Trading
- Financials
- Holders
Insider Transactions Reported by 37 Insiders of NEOGENOMICS INC
- Symbol
- NEO on Nasdaq
- Location
- Fort Myers, FL
What Changed
- Buy value: $797,569; sell value: $576,853.
- Net share flow: +65,048.
Why This Matters
- This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
- Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.
Source Evidence
Filed on Form 4
See Original Filing
Issuer insider activity is sourced from SEC Forms 3, 4, and 5.
Insider trading overview
Last 12 monthsNet insider flow leans to buying over the last 12 months. Net value: +$220,715.
Buys
$797,569
Shares: 113,010
Insiders: 8
Sells
$576,854
Shares: 47,962
Insiders: 2
Net
+$220,715
Shares: +65,048
Insiders: 6
| Window (months) | Buy shares | Sell shares | Buy $ | Sell $ | Net $ |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 43,044 | $0 | $527,674 | -$527,674 |
| 6-9 | 37,900 | 4,918 | $212,276 | $49,180 | +$163,096 |
| 9-12 | 75,110 | 0 | $585,294 | $0 | +$585,294 |
NEOGENOMICS INC executives and other stock owners filed with the SEC include:
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Douglas M. van Oort | Director | $45,677,027 | Mixed | 01 Aug 2021 | ||
| Christopher M. Smith | Chief Executive Officer | $15,690,205 | Mixed | 23 Feb 2025 | ||
| Anthony P. Zook | Chief Executive Officer, Director | $9,421,907 | +$248,872 | +2.7% | Mixed | 01 Apr 2026 |
| Mark Mallon | Chief Executive Officer, Director | $6,768,458 | Mixed | 01 Mar 2022 | ||
| Jeffrey Scott Sherman | Chief Financial Officer | $6,163,431 | +$262,426 | +4.4% | Mixed | 21 Feb 2026 |
| George Cardoza | President & COO, Lab Ops | $4,857,847 | Mixed | 01 Mar 2022 | ||
| Warren Stone | Pres & Chief Operating Officer | $4,307,530 | -$227,787 | -5% | Mixed | 01 Apr 2026 |
| Alicia C. Olivo | EVP, GC & Business Development | $4,253,789 | -$300,172 | -6.6% | Mixed | 01 Mar 2026 |
| William Bonello | Chief Financial Officer | $3,522,568 | Mixed | 28 Apr 2022 | ||
| Douglas Matthew Brown | Chief Strategy Officer | $2,918,199 | Mixed | 01 Apr 2022 | ||
| Robert J. Shovlin | President, Clinical Services | $2,760,357 | Mixed | 25 May 2021 | ||
| Halley E. Gilbert | Chief Legal Officer | $2,710,612 | Mixed | 01 Mar 2022 | ||
| Vishal Sikri | President Advanced Diagnostics | $2,687,306 | Mixed | 23 Feb 2024 | ||
| Melody Harris | Chf Ops Off, Pres, Informatics | $2,353,925 | Mixed | 21 Feb 2025 | ||
| Shashikant Kulkarni | Chief Scientific Officer | $1,520,356 | Mixed | 01 Apr 2023 | ||
| Bruce K. Crowther | Director | $1,406,026 | Mixed | 10 Aug 2023 | ||
| Alison L. Hannah | Director | $1,201,755 | Mixed | 01 Jun 2025 | ||
| Lynn A. Tetrault | Director | $998,673 | +$56,974 | +6.1% | Mixed | 01 Jun 2025 |
| Greg D. Aunan | Chief Accounting Officer | $978,439 | Mixed | 01 Mar 2026 | ||
| Kathryn B. McKenzie | Chief Sustainability/Risk Ofcr | $907,749 | Mixed | 11 Jan 2022 | ||
| Jennifer Balliet | VP and Chief Culture Officer | $894,030 | Mixed | 30 Dec 2021 | ||
| David Sholehvar | President, Clinical Services | $794,742 | Mixed | 01 Aug 2022 | ||
| Michael Aaron Kelly | Director | $785,156 | +$38,000 | +5.1% | Mixed | 01 Jun 2025 |
| Stephen M. Kanovsky | Director | $780,701 | +$31,124 | +4.2% | Mixed | 01 Jun 2025 |
| Clive Morris | President of Inivata | $759,139 | Mixed | 30 Dec 2021 | ||
| David Brian Perez | Director | $715,606 | +$76,300 | +12% | Mixed | 01 Jun 2025 |
| Kevin C. Johnson | Director | $687,749 | Mixed | 22 Dec 2021 | ||
| Gina M. Wallar | President, Pharma Services | $615,017 | Mixed | 01 Mar 2022 | ||
| Neil Gunn | Director | $594,025 | +$34,977 | +6.3% | Mixed | 01 Jun 2025 |
| Cynthia J. Dieter | Chief Accounting Officer | $547,378 | Mixed | 01 Mar 2023 | ||
| Rachel A. Stahler | Director | $392,351 | Mixed | 10 Jun 2022 | ||
| Elizabeth Floegel | Director | $374,521 | Mixed | 01 Jun 2025 | ||
| David Daly | Director | $315,922 | Mixed | 10 Jun 2022 | ||
| Felicia Williams | Director | $170,074 | Mixed | 01 Jun 2025 | ||
| Marjorie C. Green | Director | Mixed | 19 Jun 2025 | |||
| John P. Kenny | Director | Mixed | 01 Jan 2026 | |||
| Abhishek Jain | Chief Financial Officer | Mixed | 02 Mar 2026 |
Top shareholders of NEOGENOMICS INC (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. |
13F
13D/G
|
Company |
15%
from 13D/G
|
19,461,349
|
$228,865,463 | — | 31 Dec 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
11%
|
13,828,355
|
$162,621,455 | — | 31 Dec 2025 | |
| First Light Asset Management, LLC |
13F
13D/G
|
Company · Mathew P. Arens |
7.6%
from 13D/G
|
10,035,063
|
$118,012,341 | — | 31 Dec 2025 | |
| Greenhouse Funds LLLP |
13F
13D/G
|
Company |
5.8%
from 13D/G
|
8,643,846
|
$101,651,629 | — | 31 Dec 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13D/G
13F
|
Company |
5%
|
6,483,428
|
$65,352,954 | +$470,252 | 02 Dec 2025 | |
| JANUS HENDERSON GROUP PLC |
13D/G
13F
|
Company |
4.8%
|
6,165,063
|
$63,315,197 | $0 | 31 Dec 2024 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
4.1%
|
5,297,528
|
$62,298,929 | — | 31 Dec 2025 | |
| STATE STREET CORP |
13F
|
Company |
3.8%
|
4,978,292
|
$58,544,714 | — | 31 Dec 2025 | |
| BRAIDWELL LP |
13F
|
Company |
3.6%
|
4,632,801
|
$54,481,740 | — | 31 Dec 2025 | |
| SCHRODER INVESTMENT MANAGEMENT GROUP |
13F
|
Company |
3.1%
|
4,017,588
|
$49,135,101 | — | 31 Dec 2025 | |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. |
13F
|
Company |
3%
|
3,939,140
|
$46,324,000 | — | 31 Dec 2025 | |
| Douglas M. van Oort |
3/4/5
|
Director |
—
mixed-class rows
|
2,708,881
mixed-class rows
|
$45,677,027 | — | 01 Aug 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.4%
|
3,176,644
|
$37,363,823 | — | 31 Dec 2025 | |
| T. Rowe Price Investment Management, Inc. |
13D/G
13F
|
Company |
2.6%
|
3,317,169
|
$34,067,326 | $0 | 31 Mar 2025 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.9%
|
2,471,738
|
$29,067,639 | — | 31 Dec 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
1.9%
|
2,448,747
|
$28,801,373 | — | 31 Dec 2025 | |
| AMERICAN CAPITAL MANAGEMENT INC |
13F
|
Company |
1.8%
|
2,324,366
|
$27,334,544 | — | 31 Dec 2025 | |
| GW&K Investment Management, LLC |
13F
|
Company |
1.7%
|
2,238,767
|
$26,328,000 | — | 31 Dec 2025 | |
| INTEGRATED CORE STRATEGIES (US) LLC |
13D/G
|
Millennium Management LLC |
2.8%
|
3,566,808
|
$26,073,366 | -$24,761,251 | 30 Jun 2025 | |
| MORGAN STANLEY |
13F
|
Company |
1.6%
|
2,126,049
|
$25,002,359 | — | 31 Dec 2025 | |
| Aberdeen Group plc |
13F
|
Company |
1.4%
|
1,798,939
|
$21,155,523 | — | 31 Dec 2025 | |
| SEGALL BRYANT & HAMILL, LLC |
13F
|
Company |
1.3%
|
1,732,029
|
$20,368,661 | — | 31 Dec 2025 | |
| PFM Health Sciences, LP |
13F
|
Company |
1.3%
|
1,694,051
|
$19,922,040 | — | 31 Dec 2025 | |
| LOOMIS SAYLES & CO L P |
13F
|
Company |
1.3%
|
1,631,135
|
$19,182,147 | — | 31 Dec 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.1%
|
1,433,130
|
$16,853,609 | — | 31 Dec 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1.1%
|
1,423,088
|
$16,735,514 | — | 31 Dec 2025 | |
| GLENMEDE TRUST CO NA |
13F
|
Company |
1.1%
|
1,410,835
|
$16,591,418 | — | 31 Dec 2025 | |
| SAMLYN CAPITAL, LLC |
13F
|
Company |
1.1%
|
1,388,221
|
$16,325,479 | — | 31 Dec 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
1%
|
1,347,726
|
$15,849,258 | — | 31 Dec 2025 | |
| Christopher M. Smith |
3/4/5
|
Chief Executive Officer |
—
mixed-class rows
|
1,312,718
mixed-class rows
|
$15,690,205 | — | 23 Feb 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1%
|
1,307,471
|
$15,375,859 | — | 31 Dec 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.94%
|
1,217,152
|
$14,313,708 | — | 31 Dec 2025 | |
| Trexquant Investment LP |
13F
|
Company |
0.68%
|
885,530
|
$10,413,833 | — | 31 Dec 2025 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.68%
|
877,949
|
$10,324,680 | — | 31 Dec 2025 | |
| Anthony P. Zook |
3/4/5
|
Chief Executive Officer, Director |
—
mixed-class rows
|
1,108,685
mixed-class rows
|
$9,421,907 | +$248,872 | 01 Apr 2026 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.57%
|
740,017
|
$8,702,605 | — | 31 Dec 2025 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.48%
|
616,909
|
$7,254,850 | — | 31 Dec 2025 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.46%
|
593,790
|
$6,982,970 | — | 31 Dec 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.45%
|
584,035
|
$6,868,251 | — | 31 Dec 2025 | |
| Mark Mallon |
3/4/5
|
Chief Executive Officer, Director |
—
mixed-class rows
|
715,828
mixed-class rows
|
$6,768,458 | — | 01 Mar 2022 | |
| HighMark Wealth Management LLC |
13F
|
Company |
0.44%
|
567,334
|
$6,671,847 | — | 31 Dec 2025 | |
| Invesco Ltd. |
13F
|
Company |
0.42%
|
539,157
|
$6,340,487 | — | 31 Dec 2025 | |
| Jeffrey Scott Sherman |
3/4/5
|
Chief Financial Officer |
—
mixed-class rows
|
497,051
mixed-class rows
|
$6,163,431 | +$262,426 | 21 Feb 2026 | |
| PUBLIC SECTOR PENSION INVESTMENT BOARD |
13F
|
Company |
0.35%
|
447,703
|
$5,264,987 | — | 31 Dec 2025 | |
| Soleus Capital Management, L.P. |
13F
|
Company |
0.33%
|
427,504
|
$5,027,447 | — | 31 Dec 2025 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.33%
|
426,211
|
$5,012,242 | — | 31 Dec 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.33%
|
423,593
|
$4,981,454 | — | 31 Dec 2025 | |
| George Cardoza |
3/4/5
|
President & COO, Lab Ops |
—
mixed-class rows
|
304,659
mixed-class rows
|
$4,857,847 | — | 01 Mar 2022 | |
| Warren Stone |
3/4/5
|
Pres & Chief Operating Officer |
—
mixed-class rows
|
464,776
mixed-class rows
|
$4,307,530 | -$227,787 | 01 Apr 2026 | |
| Alicia C. Olivo |
3/4/5
|
EVP, GC & Business Development |
—
mixed-class rows
|
355,371
mixed-class rows
|
$4,253,789 | -$300,172 | 01 Mar 2026 |
Recent Insider Transactions by Companies or Individuals for NEOGENOMICS INC
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Warren Stone | NEO | Common Stock | Tax liability | -4.18% | -6,911 | 158,365 | 01 Apr 2026 | Direct | ||
| Warren Stone | NEO | Common Stock | Options Exercise | 11.9% | 17,562 | 165,276 | 01 Apr 2026 | Direct | ||
| Warren Stone | NEO | Restricted Stock Unit | Options Exercise | -33.3% | -17,562 | 35,125 | 01 Apr 2026 | Direct | ||
| Anthony P. Zook | NEO | Common Stock | Tax liability | -25.4% | -45,453 | 133,111 | 01 Apr 2026 | Direct | ||
| Anthony P. Zook | NEO | Common Stock | Options Exercise | 369.1% | 140,498 | 178,564 | 01 Apr 2026 | Direct | ||
| Anthony P. Zook | NEO | Restricted Stock Unit | Options Exercise | -33.3% | -140,498 | 280,998 | 01 Apr 2026 | Direct | ||
| Greg D. Aunan | NEO | Restricted Stock Unit | Award | 22,889 | 22,889 | 01 Mar 2026 | Direct | |||
| Greg D. Aunan | NEO | Stock Option (Right to Buy) | Award | 36,825 | 36,825 | 01 Mar 2026 | Direct | |||
| Alicia C. Olivo | NEO | Restricted Stock Unit | Award | 89,013 | 89,013 | 01 Mar 2026 | Direct | |||
| Alicia C. Olivo | NEO | Stock Option (Right to Buy) | Award | 147,804 | 147,804 | 01 Mar 2026 | Direct | |||
| Warren Stone | NEO | Restricted Stock Unit | Award | 152,594 | 152,594 | 01 Mar 2026 | Direct | |||
| Warren Stone | NEO | Stock Option (Right to Buy) | Award | 253,378 | 253,378 | 01 Mar 2026 | Direct | |||
| Anthony P. Zook | NEO | Restricted Stock Unit | Award | 406,918 | 406,918 | 01 Mar 2026 | Direct | |||
| Anthony P. Zook | NEO | Stock Option (Right to Buy) | Award | 675,676 | 675,676 | 01 Mar 2026 | Direct | |||
| Warren Stone | NEO | Common Stock | Tax liability | -2.2% | -3,323 | 147,714 | 23 Feb 2026 | Direct | ||
| Warren Stone | NEO | Common Stock | Options Exercise | 5.92% | 8,443 | 151,037 | 23 Feb 2026 | Direct | ||
| Warren Stone | NEO | Restricted Stock Unit | Options Exercise | -50% | -8,443 | 8,443 | 23 Feb 2026 | Direct | ||
| Jeffrey Scott Sherman | NEO | Common Stock | Tax liability | -1.69% | -3,783 | 220,009 | 23 Feb 2026 | Direct | ||
| Jeffrey Scott Sherman | NEO | Common Stock | Options Exercise | 7.46% | 15,535 | 223,792 | 23 Feb 2026 | Direct | ||
| Jeffrey Scott Sherman | NEO | Restricted Stock Unit | Options Exercise | -50% | -15,535 | 15,536 | 23 Feb 2026 | Direct | ||
| Alicia C. Olivo | NEO | Common Stock | Tax liability | -3.44% | -3,323 | 93,224 | 23 Feb 2026 | Direct | ||
| Alicia C. Olivo | NEO | Common Stock | Options Exercise | 9.58% | 8,443 | 96,547 | 23 Feb 2026 | Direct | ||
| Alicia C. Olivo | NEO | Restricted Stock Unit | Options Exercise | -50% | -8,443 | 8,443 | 23 Feb 2026 | Direct | ||
| Warren Stone | NEO | Common Stock | Tax liability | -4.77% | -7,142 | 142,594 | 21 Feb 2026 | Direct | ||
| Warren Stone | NEO | Common Stock | Options Exercise | 23.1% | 28,105 | 149,736 | 21 Feb 2026 | Direct | ||
| Warren Stone | NEO | Restricted Stock Unit | Options Exercise | -33.3% | -28,105 | 56,212 | 21 Feb 2026 | Direct | ||
| Jeffrey Scott Sherman | NEO | Common Stock | Tax liability | -4.9% | -10,729 | 208,257 | 21 Feb 2026 | Direct | ||
| Jeffrey Scott Sherman | NEO | Common Stock | Options Exercise | 23.8% | 42,158 | 218,986 | 21 Feb 2026 | Direct | ||
| Jeffrey Scott Sherman | NEO | Restricted Stock Unit | Options Exercise | -33.3% | -42,158 | 84,318 | 21 Feb 2026 | Direct | ||
| Alicia C. Olivo | NEO | Common Stock | Tax liability | -8.6% | -8,295 | 88,104 | 21 Feb 2026 | Direct | ||
| Alicia C. Olivo | NEO | Common Stock | Options Exercise | 28% | 21,079 | 96,399 | 21 Feb 2026 | Direct | ||
| Alicia C. Olivo | NEO | Restricted Stock Unit | Options Exercise | -33.3% | -21,079 | 42,159 | 21 Feb 2026 | Direct | ||
| Greg D. Aunan | NEO | Common Stock | Tax liability | -7.84% | -1,875 | 22,027 | 21 Feb 2026 | Direct | ||
| Greg D. Aunan | NEO | Common Stock | Options Exercise | 36% | 6,323 | 23,902 | 21 Feb 2026 | Direct | ||
| Greg D. Aunan | NEO | Restricted Stock Unit | Options Exercise | -33.3% | -6,323 | 12,648 | 21 Feb 2026 | Direct | ||
| Warren Stone | NEO | Common Stock | Sale | -15.4% | $276,682 | $12.50 | -22,128 | 121,631 | 20 Jan 2026 | Direct |
| Warren Stone | NEO | Common Stock | Tax liability | -9.52% | -15,127 | 143,759 | 13 Jan 2026 | Direct | ||
| Warren Stone | NEO | Common Stock | Options Exercise | 59.7% | 59,382 | 158,886 | 13 Jan 2026 | Direct | ||
| Alicia C. Olivo | NEO | Common Stock | Tax liability | -16.7% | -15,145 | 75,320 | 13 Jan 2026 | Direct | ||
| Alicia C. Olivo | NEO | Common Stock | Options Exercise | 191% | 59,382 | 90,465 | 13 Jan 2026 | Direct | ||
| John P. Kenny | NEO | Restricted Stock Unit | Award | 5,893 | 5,893 | 01 Jan 2026 | Direct | |||
| John P. Kenny | NEO | Stock Option (Right to Buy) | Award | 4,171 | 4,171 | 01 Jan 2026 | Direct | |||
| Jeffrey Scott Sherman | NEO | Common Stock | Tax liability | -6.34% | -11,938 | 176,394 | 07 Dec 2025 | Direct | ||
| Warren Stone | NEO | Common Stock | Tax liability | -8.1% | -8,776 | 99,504 | 01 Dec 2025 | Direct | ||
| Alicia C. Olivo | NEO | Common Stock | Sale | -40.2% | $250,992 | $12.00 | -20,916 | 31,083 | 25 Nov 2025 | Direct |
| Alicia C. Olivo | NEO | Common Stock | Options Exercise | 20.9% | 8,977 | 51,999 | 25 Nov 2025 | Direct | ||
| Alicia C. Olivo | NEO | Stock Option (Right to Buy) | Options Exercise | -16.2% | -8,977 | 46,355 | 25 Nov 2025 | Direct | ||
| Alicia C. Olivo | NEO | Common Stock | Sale | -10.3% | $49,180 | $10.00 | -4,918 | 43,022 | 16 Oct 2025 | Direct |
| Alicia C. Olivo | NEO | Common Stock | Tax liability | -3.36% | -1,666 | 47,940 | 01 Sep 2025 | Direct | ||
| Jeffrey Scott Sherman | NEO | Common Stock | Purchase | 11.9% | $112,322 | $5.62 | 20,000 | 188,332 | 06 Aug 2025 | Direct |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.